OpenVSafe by OpenVAERS
Search V-safe

D82-27087-62478

3 vaccinations 11 coded responses 24 check-ins 11 free-text entries 0 call cases
Sex
Female
Age at first dose
16-20
ZIP prefix
078 / NJ
Registered
2021-04-21
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-20
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-21
    Registered in v-safe
  3. 2021-04-21
    Survey response — days 1–6 daily, dose 1
    MedDRA: Chest pain — Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Chest pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-04-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  5. 2021-04-24
    Survey response — days 1–6 daily, dose 1
    MedDRA: Asthenia, Dizziness — Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Dizziness, weakness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-04-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Muscle or body aches
    Adult check-in
  7. 2021-04-27
    Health check-in — day 7, dose 1
    Feeling: Good · Site: Pain, Itching · Joint pains, Muscle or body aches, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  8. 2021-05-06
    Survey response — day 14, dose 1
    MedDRA: Pain, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities
    Free text: Some worsening of pre existing chronic pain.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-05-11
    Dose 2 — Pfizer-BioNTech
  10. 2021-05-11
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Fever · Fatigue or tiredness
    Adult check-in
  11. 2021-05-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Syncope — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Free text: Fainting
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-05-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Blindness transient, Dizziness, Lymphadenopathy, Vision blurred — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Free text: Swollen lymph nodes, feeling faint, brief vision loss/blurring
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-05-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy, Tachycardia — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activities
    Free text: Tachycardia, swollen lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-05-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  15. 2021-05-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  16. 2021-05-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: Syncope — Feeling: Fair · Headache, Fatigue or tiredness
    Free text: Fainting episode
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-05-18
    Health check-in — day 7, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  18. 2021-05-25
    Survey response — day 14, dose 2
    MedDRA: Dysmenorrhoea, Menstrual disorder, Self-medication — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Abnormal symptoms during menstruation (no/very little flow and periods of extreme pain not controlled by multiple pain medications and heat when they usually are)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-06-01
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  20. 2021-06-08
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  21. 2021-06-15
    Survey response — day 35, dose 2
    MedDRA: Abdominal pain, Acne, Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Worsening abdominal pain, acne, and hidradenitis suppurtiva
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-06-22
    Survey response — day 42, dose 2
    MedDRA: Pain, Pre-existing disease, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Worsening chronic pain and tachycardia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-08-10
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  24. 2021-11-09
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  25. 2022-03-27
    Dose 3 — Pfizer-BioNTech
  26. 2022-05-02
    Health check-in — day 35, dose 3
    Feeling: Fair
    Adult check-in
  27. 2022-05-08
    Survey response — day 42, dose 3
    MedDRA: Condition aggravated, Hypersensitivity, Pre-existing disease — Feeling: Poor
    Free text: Worsened allergies and Hidradenitis Suppurativa flare up.
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-06-26
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-20Pfizer-BioNTech
22021-05-11Pfizer-BioNTech
32022-03-27Pfizer-BioNTech No

Free text

Release 7 — days 1–6 daily, dose 1

2021-04-21

Systemic reaction (other): Chest pain

2021-04-24

Systemic reaction (other): Dizziness, weakness

Release 8 — day 14, dose 1

2021-05-06

Symptoms: Some worsening of pre existing chronic pain.

Release 8 — days 1–6 daily, dose 2

2021-05-12

Systemic reaction (other): Fainting

2021-05-13

Systemic reaction (other): Swollen lymph nodes, feeling faint, brief vision loss/blurring

2021-05-14

Systemic reaction (other): Tachycardia, swollen lymph nodes

2021-05-17

Systemic reaction (other): Fainting episode

Release 8 — day 14, dose 2

2021-05-25

Symptoms: Abnormal symptoms during menstruation (no/very little flow and periods of extreme pain not controlled by multiple pain medications and heat when they usually are)

Release 9 — day 35, dose 2

2021-06-15

Symptoms: Worsening abdominal pain, acne, and hidradenitis suppurtiva

Release 9 — day 42, dose 2

2021-06-22

Symptoms: Worsening chronic pain and tachycardia

Release 11 — day 42, dose 3

2022-05-08

Symptoms: Worsened allergies and Hidradenitis Suppurativa flare up.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal pain ✓ ✓ ✓
SDAcne ✓ ✓ ✓
SDCondition aggravated ✓ ✓ ✓
SDDysmenorrhoea ✓ ✓ ✓
SDHypersensitivity · · ✓
SDMenstrual disorder ✓ ✓ ✓
SDPain ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDSelf-medication ✓ ✓ ✓
SDTachycardia ✓ ✓ ✓
SROAsthenia ✓ ✓ ✓
SROBlindness transient ✓ ✓ ✓
SROChest pain ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SROSyncope ✓ ✓ ✓
SROTachycardia ✓ ✓ ✓
SROVision blurred ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release